福斯科林改善了男性生殖并发症由高血糖在2型糖尿病大鼠引起的
Mehran Naghibi1,2, Hamid Tayefi Nasrabadi2, Jafar Soleimani Rad2
1Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
International journal of fertility & sterility
|August 14, 2023
概括
福斯科林通过改善精子健康和水平,有效地对抗2型糖尿病的男性不孕症. 这项研究表明, Forskolin 在大鼠中显著逆转了糖尿病引起的生殖功能障碍.
科学领域:
- 生殖生物学 生殖生物学
- 内分泌学 在内分泌学.
- 糖尿病学 糖尿病学
背景情况:
- 2型糖尿病经常导致由于精子生成并发症而导致男性不孕.
- 男性生殖功能障碍是糖尿病患者的一个重大问题.
研究的目的:
- 为了研究 Forskolin 对 2 型糖尿病引起的男性生殖功能障碍的治疗作用.
- 评估 Forskolin 对糖尿病大鼠关键生殖参数和氧化应激标志物的影响.
主要方法:
- 在Wistar大鼠中,使用高脂肪饮食和链毒素 (STZ) 诱导了2型糖尿病.
- 糖尿病老鼠接受了福斯科林 (10毫克/公斤) 治疗一个月.
- 分析了关键参数,包括血糖,水平,精子参数,氧化应激标志物 (MDA,SOD,GPX) 和基因表达 (Bax,Bcl-2).
主要成果:
- 糖尿病老鼠表现出显著增加的血糖,体重和MDA水平,同时降低了丸激素,精子质量和抗氧化酶活性.
- 福斯科林治疗 (G4) 将这些参数正常化,使它们更接近对照组水平.
- 福斯科林显著改善了糖尿病老鼠的精子度,运动性,形态,水平和抗氧化剂状况.
结论:
- 福斯科林作为抗糖尿病剂在改善男性生殖健康方面表现出显著的有效性.
- 该研究强调了福斯科林通过提高精子参数和生产来逆转糖尿病相关的不孕症的潜力.
- 福斯科林治疗有效地减轻氧化应激,并调节糖尿病丸中与亡相关的基因表达.
相关概念视频
01:23Infertility in Males
295
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
295
01:22Diabetes Mellitus: Type 2 and Gestational
2.5K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.5K
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
234
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
234